Profil
Gabriel Yariv was the founder of Instituto Simutec, founded in 2010, where the title held was Chief Executive Officer from 2010 to 2017.
Mr. Yariv was the founder of The Yariv Foundation For Leadership Ltd., founded in 2006, where the title held was Chief Executive Officer from 2006 to 2009.
Mr. Yariv currently holds the positions of Chairman & Chief Operating Officer at CNBX Pharmaceuticals, Inc. since 2019, Director at TaGeza Biopharmaceuticals Ltd., and Member at Friends of The Israel Museum Society.
Mr. Yariv completed undergraduate education at Boston University.
Postes actifs de Gabriel Yariv
| Sociétés | Poste | Début |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Président | 05/09/2021 |
Friends of The Israel Museum Society | Corporate Officer/Principal | - |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy and cancer-targeted pharmaceuticals | Directeur/Membre du Conseil | - |
Anciens postes connus de Gabriel Yariv
| Sociétés | Poste | Fin |
|---|---|---|
Instituto Simutec | Directeur Général | 01/01/2017 |
The Yariv Foundation For Leadership Ltd. | Directeur Général | 01/01/2009 |
Formation de Gabriel Yariv
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
CNBX Pharmaceuticals, Inc.
CNBX Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto Simutec | |
Friends of The Israel Museum Society | |
The Yariv Foundation For Leadership Ltd. | |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy and cancer-targeted pharmaceuticals | Health Technology |
















